Black Diamond Therapeutic...

1.92
-0.09 (-4.48%)
At close: Mar 03, 2025, 3:59 PM
1.91
-0.52%
After-hours: Mar 03, 2025, 04:30 PM EST

Black Diamond Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 437K 3.24M 2.22M 600K 47K 44K 24K
Gross Profit -437K -3.24M -2.22M -600K -47K -44K -24K
Operating Income -86.46M -92.83M -126.87M -69.57M -8.9M -8.9M -4.12M
Interest Income 1.92M 2.03M 3.46M 4.04M 461K 4K n/a
Pretax Income -82.44M -88.92M -125.6M -67.25M -35.26M -8.93M -4.6M
Net Income -82.44M -84.52M -123.2M -65.48M -41.14M -8.93M -4.6M
Selling & General & Admin 27.11M 28.39M 30.04M 21.36M 7.58M 1.95M 666K
Research & Development 58.91M 64.44M 96.83M 48.21M 21.75M 6.95M 3.45M
Other Expenses n/a -354K -2.19M -1.72M 6K -16K -6K
Operating Expenses 86.46M 92.83M 126.87M 69.57M 29.33M 8.9M 4.12M
Interest Expense n/a n/a n/a 1K n/a n/a 65K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 86.46M 92.83M 126.87M 69.57M 29.33M 8.9M 4.12M
Income Tax n/a -4.4M -2.39M -1.77M 5.88M -27K 59K
Shares Outstanding (Basic) 43.95M 36.33M 36.19M 32.91M 35.91M 13.95M 7.2M
Shares Outstanding (Diluted) 43.95M 36.33M 36.19M 32.91M 35.91M 13.95M 7.2M
EPS (Basic) -1.88 -2.33 -3.4 -1.99 -1.15 -0.64 -0.64
EPS (Diluted) -1.88 -2.33 -3.4 -1.99 -1.15 -0.64 -0.64
EBITDA -86.02M -92.32M -126.67M -66.65M -29.29M -8.89M -4.09M
Depreciation & Amortization 437K 3.24M 2.22M 600K 47K 44K 24K